Unfortunately. I am not surprised by the number of people who switch positions/say they know what’s going and blame Elite like it’s their fault the PPS is always down. Obviously, those people haven’t been around years ago to compare now and then. If they were they’d understand that ELTP has come a very long way and is still only in the beginning stage of its transformation with much yet to come.
Let me first try to explain where Elite is currently. PPS is the biggest complaint here, I understand, but there is a big difference between an R/D company vs. a Company that has revenue and also has an R/D. a pure R/D the pps is based on potential market of that specific drug. If Elite was still only an R/D we’d be valued higher right now. Unfortunately, we also have small revenue (because it’s in ELTPs best interest to help self-fund operations, even if it’s by a little) since we have small rev compared to industry we are valued for the amount of money we bring in. Later the P/E makes us worth several $.
Remember, there are things that go on a daily basis that we as common shareholders don’t know. Another thing to mention is that ELTP can make some executive decisions without our approval. With that noted, there are specific agreements/arrangements in place for practically everything. Jeenarine leaving the company could be one of those things. Mr. Pfeifer actually helps ElTP with the Regulatory side of the business the tech is solid lets focus on the commercial side now. Jeenarine still owns 13 mil shares. I like that Nasrat put some shares in his IRA that is an indicator that he believes the PPS will be high enough to have him retire nicely as well. Treppel still has 7 mil too.
ART is cheaper to produce, easier to equip to other opioids, since its plug/play they can easily develop and test other ART, it’s a resistant more so deterrent.
With the addition of Humanwell/Puracap they could help Elite internationally. US pain market 7-10 bil; international 50B.
Sentiment: Strong Buy
I do wish to make a public statement and acknowledge my error. I did make a mistake and added Califf instead of one of the insiders name. Thank you to those who pointed that out. I wasn't trying to put up spam pump of any sorts I am not scared to admit my mistake.
Moving on with what matters is that the article stated that there is a huge need to cut abuse. FDA is pressured and Mr. Califf mentioned he'd do what it takes to curb this epidemic. The fact that Elite is now being mentioned in bigger media makes me believe that we will see more articles pop out talking about Elite that will put us in the spotlight. Its always quiet before the storm. By the time we get closer to target date there will be a lot of pumping going on. Bashers will begin to take their positions thinking worse case scenario and the day we get halted for FDA decision and we finally get approve the stock will rocket with short sellers trying to cover and bigger players buying their stakes. That will be a very nice day that I look forward too.
Again, sorry for the mistake and everyone enjoy the week ahead.
Sentiment: Strong Buy
I pulled this portion from an article on the opioid epidemic. If you wish to read search Robert Califf abuse deterrent drugs. Mr. Califf stated; "True ADT formulations need work and are in their infancy. However, what are the alternatives to date? If I was a physician, I would rather prescribe an ADT opioid than I know cannot be crushed, snorted or injected as opposed to one that can easily be defeated. For that I am looking for a small company named Elite pharmaceuticals to come out with an ADT technology similar to Pfizer's ADT technology. The difference? Pfizer's ADT can be defeated by heating it. Elite's cannot".
Hmm, now who said no one was paying attention to Elite? Well I can tell you that the FDA sure as hell is keeping close watch on lil ol' Elite. Basically in the article they said that Elite's tech was superior in comparison to that of Pfizer's. Pfizer bought out King Pharma for their drug Embeda (and some other irrelevant drugs) for 3.6B. If the company was purchased for that amount, what do you think a company with a superior product is worth?
Nasrat said that he was Elites biggest advocate. He should be he is the largest shareholder of course he wants to maximize his gains. However, he knows Elite will need some work fixing its financials, but that can be easily taken care of once SequestOx is out. Its not true that there isnt interest in Elite. Some companies can't invest in a company this low and that is understandable. When Elite is approved big boys will jump all over this stock Watch and see. Nasrat 's agenda is getting as much drugs to market with uplisting waiting until another year. I personally don't believe there will be a buyout soon rather we will in a couple of years when we proven to control a large portion of the market I'll take $15 instead of a quick $2 any day.
I truly believe Elite will play their cards well and control the opioid market, now with a foreign company buying Epic maybe we can take a portion of international too.
Sentiment: Strong Buy
I honestly don't like the hub's mb because its easy for one to be a mod and ban the views of those who oppose their value. If someone wants to stoop to a level to pretend be someone else, fine, but I can tell you that I am the only one hence the 1 at the end of my username who can be stockboy1. I haven't nor will i ever create another id because that would be as dumb as some of the others who spend their lives on this board harassing others.
Although, I don't want to be labelled as a DA or person who should be ignored, however if that is how you feel please do so. I won't lose any sleep over insignificant matters such as why the stock was down 0.05% and or why the stock won't perform like one of warren buffett's stock after news. Somethings are out of most peoples control so deal with it. The real reason Elite's PPS has been stagnant and fizzling out after news is because people know that Elite is not out of the woods yet. So shorts will continue to drag the price to resistance (holders not willing to budge/sell) There are people waiting for the FDA target day to see what the professionals have to say about the tech. If they believe its great then guess what? others will too.
Its like I said before I wont lose sleep over this matter I did my DD and is pleased with the results on a fundamental basis with growth being the prize for us holders.
If someone wants to pretend to be me to make me look bad or get viewers to read their posts go for it. Ill remember that when I drink my long island bny my lake house and celebrating Elites success and all the humorous mb topics/comments. REMEMBER IT TAKES MONEY TO MAKE MONEY. Elite is inquiring huge expenses, but after all generics launch and SequestOx we will be able to fund operations no problem. Added bonus tech is plug and play so don't expect more costly liabilities later. It will take time, but we will get their patience is a virtue. done warren B., well we can do it too. Enjoy the rest of your week/ GL
Sentiment: Strong Buy
Everyone enjoying the market volatility? I know I am I have been loading up on many of my favorite companies which includes Elite. Its been awhile since I looked at this board, but now that I am here I would like to try to clear the polluted air that plagues this mb. First of all the short interest (although it has been decreasing in the past months) remains pretty high. In all honesty that is fine by me, please continue it will assure me even more shares from now until FDA decision. Elite has done incredible things to get where it is today. If anything everyone should be grateful to ELTP for trying to create value. I mean ELTP could've turned out like AMBS. So be happy Elite is in a position to make great things happen. Once FDA gives approval thats when people get the green light they know that FDA wouldnt just approve any drug to market.
Elite was never a failure company, it was crippled in the past when their lead generic was pulled by FDA and stripped ELTP of its money making ability. That coupled with expensive R/D and a market crash Elite as a company would have gone bankrupt. if it wasn't for others coming to Elites aid. Their opioid drugs were always and possibly is the best in class in terms of tech. So I truly believe that once we begin selling SequestOx This company will fire on all cylinders and then begin on fixing the share structure and company's' balance sheet.
As far as Mr. Treppel and his continues selling we need to understand that there must have been negotiations that lead to his selling, or could have been to recover some money for whatever he wishes to use his money. Either way, he still owns a good amount to make him happier later. One thing to note is that for everyone selling there seems to be a buyer which is good, and those buyers are starting to hold on tighter to those shares.
Overall, Elite is growing pretty well as it is now, but once SequestOx hits the market and we begin to make money off of it watch what happens to the stock pps
Sentiment: Strong Buy
I'd would just like to say that I am pleased with my investment here. I do not fret when the PPS sinks 1-6% on a daily basis I didn't come here to day trade this stock. I will hold until Elite's plans come to fruition. I understand some here might be upset because they bought in at a higher price and are now down. Its understandable, in due time you'll be able to recover, in the mean time average down (If you wish). I, however, am lucky that i bought and hold an average $.225 So far my plan has done well. Buy in the dips and forget the daily movements.
Believe it or not the company has done things it never even did during its time listed on AMEX when the stock was worth $22. We have proof that Elite has done very well on their studies. We received top line results for our last phase 3. With FDA stressed to make changes in the pain market, Elite couldn't be in a better position then it is already is to take on the opioid problem. Having Lincoln Park to add support for Elite to be able to fund operation is nice, but not necessarily needed. Better to have credit and not use it, than to need it and not have it. Generics currently will help us by adding supplemental cash, eventually having all generics will support most operational needs. Financially Elite has done very well others in our area only have their own opioid deterrent and nothing else.
conference call was quite positive, but he did mention that if we don't increase the PPS we will need to reverse split. Other than that it was great. I on the other hand believe that a R/S will not be needed. He said himself that uplisting is on the agenda, but not going to be rushed we have roughly a year before that comes up as a bigger priority, right now its getting SequestOx finalized. Generics coupled with SequestOx we will meet the minimal requirements to uplist to Nasdaq organically. The Share price of Elite will get us past a couple of dollar easily when FDA approve us. People who've been watching will jump in.
Sentiment: Strong Buy